Side-effects of post-treatment biopsies in prostate cancer patients treated with endocrine therapy alone or combined with radical radiotherapy in the Scandinavian Prostate Cancer Group-7 randomized trial

References

• Zelefsky MJ, Reuter VE, Fuks Z, Scardino P, Shippy A. Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer. J Urol 2008;179:1368–73; discussion 73.
   Google Scholar
• Vance W, Tucker SL, de Crevoisier R, Kuban DA, Cheung MR. The predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome. Int J Radiat Oncol Biol Phys 2007;67:828–33.
   PubMed Web of Science ®Google Scholar
• Crook JM, Malone S, Perry G, Eapen L, Owen J, Robertson S, Twenty-four-month postradiation prostate biopsies are strongly predictive of 7-year disease-free survival:results from a Canadian randomized trial. Cancer 2009;115:673–9.
   PubMed Web of Science ®Google Scholar
• Berge V, Baco E, Karlsen SJ. A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer:early results. Scand J Urol Nephrol 2010;44:223–7.
   PubMed Web of Science ®Google Scholar
• Bahn DK, Lee F, Silverman P, Bahn E, Badalament R, Kumar A, Salvage cryosurgery for recurrent prostate cancer after radiation therapy:a seven-year follow-up. Clin Prostate Cancer 2003;2:111–14.
   PubMedGoogle Scholar
• Bianco FJ Jr, Scardino PT, Stephenson AJ, Diblasio CJ, Fearn PA, Eastham JA. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2005;62:448–53.
   PubMed Web of Science ®Google Scholar
• Djavan B, Waldert M, Zlotta A, Dobronski P, Seitz C, Remzi M, Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies:results of a prospective European prostate cancer detection study. J Urol 2001;166:856–60.
   PubMed Web of Science ®Google Scholar
• Peyromaure M, Ravery V, Messas A, Toublanc M, Boccon-Gibod L. Pain and morbidity of an extensive prostate 10-biopsy protocol:a prospective study in 289 patients. J Urol 2002;167:218–21.
   PubMed Web of Science ®Google Scholar
• Berger AP, Gozzi C, Steiner H, Frauscher F, Varkarakis J, Rogatsch H, Complication rate of transrectal ultrasound guided prostate biopsy:a comparison among 3 protocols with 6, 10 and 15 cores. J Urol 2004;171:1478–80; discussion 80–1.
   Google Scholar
• Sieber PR, Rommel FM, Theodoran CG, Hong RD, Del Terzo MA. Contemporary prostate biopsy complication rates in community-based urology practice. Urology 2007;70:498–500.
   PubMed Web of Science ®Google Scholar
• Kapoor DA, Klimberg IW, Malek GH, Wegenke JD, Cox CE, Patterson AL, Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 1998;52:552–8.
   PubMed Web of Science ®Google Scholar
• Deliveliotis C, John V, Louras G, Andreas S, Alargof E, Sofras F, Multiple transrectal ultrasound guided prostatic biopsies:morbidity and tolerance. Int Urol Nephrol 1999;31:681–6.
   PubMedGoogle Scholar
• Argyropoulos AN, Doumas K, Farmakis A, Liakatas I, Gkialas I, Lykourinas M. Time of administration of a single dose of oral levofloxacin and its effect in infectious complications from transrectal prostate biopsy. Int Urol Nephrol 2007;39:897–903.
   PubMed Web of Science ®Google Scholar
• Yurdakul T, Taspinar B, Kilic O, Kilinc M, Serarslan A. Topical and long-acting local anesthetic for prostate biopsy:a prospective randomized placebo-controlled study. Urol Int 2009;83:151–4.
   PubMed Web of Science ®Google Scholar
• Leibovici D, Zisman A, Siegel YI, Sella A, Kleinmann J, Lindner A. Local anesthesia for prostate biopsy by periprostatic lidocaine injection:a double-blind placebo controlled study. J Urol 2002;167:563–5.
   PubMed Web of Science ®Google Scholar
• Gurbuz C, Canat L, Bayram G, Gokhan A, Samet G, Caskurlu T. Visual pain score during transrectal ultrasound-guided prostate biopsy using no anaesthesia or three different types of local anaesthetic application. Scand J Urol Nephrol 2010;44:212–16.
   PubMed Web of Science ®Google Scholar
• Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3):an open randomised phase III trial. Lancet 2009;373:301–8.
   PubMed Web of Science ®Google Scholar
• Solberg A, Haugen OA, Viset T, Bergh A, Tasdemir I, Ahlgren G, Residual prostate cancer in patients treated with endocrine therapy with or without radical radiotherapy: a side study of the SPCG-7 randomized trial. Int J Radiat Oncol Biol Phys 2010;Jun 30. [Epub ahead of print].
   Google Scholar
• Collins GN, Lloyd SN, Hehir M, McKelvie GB. Multiple transrectal ultrasound-guided prostatic biopsies – true morbidity and patient acceptance. Br J Urol 1993;71:460–3.
   PubMedGoogle Scholar
• Clements R, Aideyan OU, Griffiths GJ, Peeling WB. Side effects and patient acceptability of transrectal biopsy of the prostate. Clin Radiol 1993;47:125–6.
   PubMed Web of Science ®Google Scholar
• Von Korff M, Jensen MP, Karoly P. Assessing global pain severity by self-report in clinical and health services research. Spine (Phila Pa 1976) 2000;25:3140–51.
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, The European Organization for Research and Treatment of Cancer QLQ-C30:a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–76.
   PubMed Web of Science ®Google Scholar
• Paul R, Scholer S, van Randenborgh H, Kubler H, Alschibaja M, Busch R, Optimization of prostatic biopsy:a prospective randomized trial comparing the sextant biopsy with a 10-core biopsy. Impact of prostatic region of sampling. Urol Int 2005;74:203–8.
   PubMed Web of Science ®Google Scholar
• Lilleby W, Dale E, Olsen DR, Gude U, Fossa SD. Changes in treatment volume of hormonally treated and untreated cancerous prostate and its impact on rectal dose. Acta Oncol 2003;42:10–14.
   PubMed Web of Science ®Google Scholar
• Milano MT, Constine LS, Okunieff P. Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol 2007;17:131–40.
   PubMed Web of Science ®Google Scholar
• O'Brien PC. Radiation injury of the rectum. Radiother Oncol 2001;60:1–14.
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:1124–9.
   PubMed Web of Science ®Google Scholar
• Fransson P, Lund JA, Damber JE, Klepp O, Wiklund F, Fossa S, Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy:4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial. Lancet Oncol 2009;10:370–80.
   PubMed Web of Science ®Google Scholar
• Boerema JB, Dalhoff A, Debruyne FM. Ciprofloxacin distribution in prostatic tissue and fluid following oral administration. Chemotherapy 1985;31:13–18.
   PubMed Web of Science ®Google Scholar